Pelthos Therapeutics (PTHS) Current Assets (2022 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Current Assets of $53.4 million for Q4 2025, up 3801.39% year-over-year from $1.4 million in Q4 2024, and up 7.33% quarter-over-quarter from $49.8 million in Q3 2025.
Pelthos Therapeutics (PTHS) Current Assets (2022 - 2026) Analysis & Trends
Pelthos Therapeutics' Current Assets history runs 4 years deep, the most recent figure standing at $53.4 million for Q4 2025.
- In Q4 2025, Current Assets rose 3801.39% year-over-year to $53.4 million; the TTM figure through Dec 2025 stood at $53.4 million (up 3801.39% YoY), while the FY2025 annual figure was $53.4 million, up 3801.39% from the prior year.
- Current Assets for Q4 2025 stood at $53.4 million, up from $49.8 million in the prior quarter.
- The five-year high for Current Assets was $53.4 million in Q4 2025, with the low at $55074.0 in Q4 2022.
- The 4-year median for Current Assets is $1.8 million (2024), against an average of $11.5 million.
- Peak annual rise in Current Assets reached 3801.39% in 2025, while the deepest fall reached 77.4% in 2025.
- Pelthos Therapeutics' Current Assets stood at $55074.0 in 2022, then surged by 75.02% to $96391.0 in 2023, then surged by 1320.26% to $1.4 million in 2024, then jumped by 3801.39% to $53.4 million in 2025.
- Business Quant data shows PTHS's Current Assets at $53.4 million in Q4 2025, $49.8 million in Q3 2025, and $822850.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Pelthos Therapeutics | 96.56 Mn | 72.00 Mn | 21.23 Mn | 63.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.36 Mn |
| Dec 31, 2025 | 53.41 Mn |
| Sep 30, 2025 | 49.76 Mn |
| Jun 30, 2025 | 822,850.00 |
| Mar 31, 2025 | 911,179.00 |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 4.03 Mn |
| Dec 31, 2023 | 96,391.00 |
| Dec 31, 2022 | 55,074.00 |